Librarian sues, says Alaska health policy is discriminatory

JUNEAU, Alaska – A transgender woman is suing the state of Alaska, saying she was denied coverage for medically necessary surgical treatment.

The federal lawsuit, filed on behalf of Jennifer Fletcher, says the state health insurance plan excludes coverage for surgical treatment for gender dysphoria.

The lawsuit states that because the only people who require medically necessary care to treat gender dysphoria are transgender, denying coverage for such health care discriminates against transgender people.

Fletcher works as a legislative librarian. The lawsuit says she has been forced to pay thousands of dollars in out-of-pocket costs for health care costs not covered by her insurance plan.

The lawsuit seeks an unspecified amount in damages.

An email seeking comment was left with a state Department of Law spokeswoman Tuesday.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23